Published in
Lippincott, Williams & Wilkins, Anti-Cancer Drugs, 3(23), p. 321-325, 2012
DOI: 10.1097/cad.0b013e32834ea5d0
Elsevier, Gynecologic Oncology, (125), p. S21-S22
DOI: 10.1016/j.ygyno.2011.12.051
Links
Tools
Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer
Journal article published in 2012 by
Y. Lee,
Jong Ha Hwang,
Heon Jong Yoo 
,
Myong Cheol Lim ,
Sang-Soo Seo,
Sang-Yoon Park,
Sokbom Kang
,
Myong Cheol Lim ,
Sang-Soo Seo,
Sang-Yoon Park,
Sokbom Kang
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 